BioAdaptives, Inc.
BDPT
$0.0653
-$0.0147-18.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -888.83% | 79.45% | 40.33% | -14.31% | -1,948.09% |
| Total Depreciation and Amortization | -- | -- | -100.00% | 117.59% | -128.72% |
| Total Amortization of Deferred Charges | -- | -100.00% | -81.00% | 62.50% | 174.75% |
| Total Other Non-Cash Items | 435.11% | -198.95% | -53.04% | 20.70% | 267.94% |
| Change in Net Operating Assets | -158.03% | 167.02% | 64.91% | 344.29% | -176.92% |
| Cash from Operations | -78.51% | -9.32% | -25.00% | 54.87% | -62.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 94.10% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.10% | 211.53% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.19% | 325.26% | 52.91% | 54.87% | -181.52% |